Dr. Eduardo Parra-Davila, MD

Dr. Parra-Davila practices at Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare.

Dr. Parra-Davila's NPI, 1609864925, was assigned on October 11, 2005. Dr. Parra-Davila graduated from University of the Andes School of Medicine in 1988. Dr. Parra-Davila holds Florida license ME73141.

Dr. Parra-Davila's primary practice is Good Samaritan Medical Center, at 1309 N Flagler Dr, West Palm Beach, FL 33401 in Palm Beach County. The practice phone is (561) 655-5511.

Dr. Parra-Davila's primary practice is Good Samaritan Medical Center in West Palm Beach, Florida, part of Tenet Healthcare. Dr. Parra-Davila is also affiliated with Palm Beach Gardens Medical Center. The medical group on file is Palm Beach Health Network Physician Group. Dmand AI also links Dr. Parra-Davila to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Parra-Davila practices, 2 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Parra-Davila's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Parra-Davila is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dr. Parra-Davila is licensed in Florida.

Dmand AI lists colon removal and hemorrhoids among the conditions Dr. Parra-Davila treats.

CMS data shows 733 Medicare services from Dr. Parra-Davila across 6 procedure codes in 2024, for 306 Medicare patients. Medicare paid $68,838 for them.

CMS counts 306 Medicare patients who saw Dr. Parra-Davila in 2024. The largest group is 65 to 74, with 135 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Parra-Davila's median patient age at 62, with 54% women.

In 2024, Dr. Parra-Davila wrote 178 Medicare Part D claims for 74 patients. 93% of them were for generic drugs. CMS names the drug for 111 of them, across 3 drugs with 11 or more claims each, at $2,778 in total drug cost. In 2023, CMS named 115 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Parra-Davila for performance year 2024, reported as part of a group. Dr. Parra-Davila accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 25 procedures of hernia repair (minimally invasive) by Dr. Parra-Davila, more than 92% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Parra-Davila, published from 2009 to 2022. 2021 was the busiest year, with 3. The most frequent topics are Robotic Surgical Procedures, Rectal Neoplasms and Anal Canal. Dr. Parra-Davila has published most often in Tech Coloproctol. Dr. Parra-Davila's most frequent co-authors are Jacob A. Greenberg, MD, Gary J. Anthone, MD and Raymond Michael Dunn, MD.

CMS Open Payments shows 849 general payments to Dr. Parra-Davila from 43 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 36% of the total. Davol Inc. paid the most, $341,800.

Dmand AI lists 1 award for Dr. Parra-Davila.

Dr. Parra-Davila graduated from University of the Andes School of Medicine in 1988. Dr. Parra-Davila is a member of ACS.

Dr. Parra-Davila is in network with 20 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.